Target Price | $193.97 |
Price | $126.51 |
Potential |
53.32%
register free of charge
|
Number of Estimates | 15 |
15 Analysts have issued a price target Ascendis Pharma A/S Sponsored ADR 2025 .
The average Ascendis Pharma A/S Sponsored ADR target price is $193.97.
This is
53.32%
register free of charge
$289.64
128.94%
register free of charge
$160.35
26.75%
register free of charge
|
|
A rating was issued by 15 analysts: 14 Analysts recommend Ascendis Pharma A/S Sponsored ADR to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Ascendis Pharma A/S Sponsored ADR stock has an average upside potential 2025 of
53.32%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 288.35 | 318.45 |
436.17% | 10.44% | |
EBITDA Margin | -163.71% | -98.62% |
84.60% | 39.76% | |
Net Margin | -183.97% | -135.19% |
84.22% | 26.52% |
14 Analysts have issued a sales forecast Ascendis Pharma A/S Sponsored ADR 2024 . The average Ascendis Pharma A/S Sponsored ADR sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Ascendis Pharma A/S Sponsored ADR EBITDA forecast 2024. The average Ascendis Pharma A/S Sponsored ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Ascendis Pharma A/S Sponsored ADR Analysts have issued a net profit forecast 2024. The average Ascendis Pharma A/S Sponsored ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -9.25 | -7.51 |
15.37% | 18.81% | |
P/E | negative | |
EV/Sales | 24.18 |
6 Analysts have issued a Ascendis Pharma A/S Sponsored ADR forecast for earnings per share. The average Ascendis Pharma A/S Sponsored ADR <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Ascendis Pharma A/S Sponsored ADR stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Ascendis Pharma A/S Sponsored ADR...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.